ask="2.18"
ask_size="800"
average_daily_volume="1997910"
bid="2.11"
bid_size="200"
book_value="4.54"
change="-0.02"
change_from_200_day_moving_average="-0.53"
change_from_50_day_moving_average="-0.08"
change_from_52_week_high="-1.71"
change_From_52_week_low="0.20"
change_in_percent="-0.93%"
close="2.13"
dividend_pay_date="6/13/2016"
dividend_per_share="0.20"
dividend_yield="0.00"
earnings_per_share="0.39"
ebitda="149.51M"
eps_estimate_current_year="0.18"
eps_estimate_next_quarter="0.05"
eps_estimate_next_year="0.41"
ex_dividend_date="6/2/2016"
float_shares="149095000"
high="2.18"
high_52_weeks="3.84"
last_trade_date="3/14/2017"
last_trade_price="2.13"
last_trade_size="68604"
last_trade_time="4:00pm"
low="2.11"
low_52_weeks="1.93"
market_capitalization="352.64M"
moving_average_200_day="2.66"
moving_average_50_day="2.21"
name="PDL BioPharma
Inc."
notes="N/A"
one_year_target_price="3.67"
open="2.14"
pe_ratio="5.49"
peg_ratio="0.85"
percent_change_from_200_day_moving_average="-19.93%"
percent_change_from_50_day_moving_average="-3.72%"
percent_change_from_52_week_high="-44.53%"
percent_change_from_52_week_low="+10.36%"
previous_close="2.15"
price_eps_estimate_current_year="11.83"
price_eps_Estimate_next_year="5.20"
price_per_book="0.47"
price_per_sales="1.80"
revenue="197.70M"
shares_outstanding="165558000"
short_ratio="7.12"
stock_exchange="NMS"
symbol="PDLI"
volume="1311115"
weeks_range_52="1.93 - 3.84"
